Extranodal NK-T-cell lymphoma: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
No edit summary
Line 1: Line 1:
__NOTOC__
{{Infobox Disease
{{Infobox Disease
  | Name          = {{PAGENAME}}
  | Name          = {{PAGENAME}}
Line 13: Line 14:
  | MeshID        = D054391
  | MeshID        = D054391
}}
}}
{{SI}}


{{CMG}}


{{SK}}


'''Extranodal NK-T-cell lymphoma''' is a type of [[lymphoma]].<ref name="pmid16380410">{{cite journal |author=Lee J, Suh C, Park YH, ''et al'' |title=Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study |journal=J. Clin. Oncol. |volume=24 |issue=4 |pages=612–8 |year=2006 |month=February |pmid=16380410 |doi=10.1200/JCO.2005.04.1384 |url=http://www.jco.org/cgi/pmidlookup?view=long&pmid=16380410}}</ref><ref name="pmid15963893">{{cite journal |author=Lee J, Park YH, Kim WS, ''et al'' |title=Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy |journal=Eur. J. Cancer |volume=41 |issue=10 |pages=1402–8 |year=2005 |month=July |pmid=15963893 |doi=10.1016/j.ejca.2005.03.010 |url=http://linkinghub.elsevier.com/retrieve/pii/S0959-8049(05)00218-2}}</ref><ref name="pmid19041057">{{cite journal |author=Lee J, Au WY, Park MJ, ''et al'' |title=Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study |journal=Biol. Blood Marrow Transplant. |volume=14 |issue=12 |pages=1356–64 |year=2008 |month=December |pmid=19041057 |doi=10.1016/j.bbmt.2008.09.014 |url=http://linkinghub.elsevier.com/retrieve/pii/S1083-8791(08)00405-9}}</ref>
== [[Extranodal NK-T-cell lymphoma overview|Overview]] ==


It is called "extranodal" to emphasize that the location is not in the [[lymph node]]. It is sometimes further qualified as "nasal type".
== [[Extranodal NK-T-cell lymphoma historical perspective|Historical Perspective]]==


It can be associated with [[Epstein Barr virus]].<ref name="pmid11727268">{{cite journal |author=Stadlmann S, Fend F, Moser P, Obrist P, Greil R, Dirnhofer S |title=Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature |journal=Hum. Pathol. |volume=32 |issue=11 |pages=1264–8 |year=2001 |month=November |pmid=11727268 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0046817701559572}}</ref><ref name="pmid19033930">{{cite journal |author=Ferenczi K, Summers P, Aubert P, ''et al'' |title=A case of CD30+ nasal natural killer/T-cell lymphoma |journal=Am J Dermatopathol |volume=30 |issue=6 |pages=567–71 |year=2008 |month=December |pmid=19033930 |doi=10.1097/DAD.0b013e318184bc3f |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000372-200812000-00006}}</ref>
== [[Extranodal NK-T-cell lymphoma classification|Classification]] ==
 
== [[Extranodal NK-T-cell lymphoma pathophysiology|Pathophysiology]] ==
 
== [[Extranodal NK-T-cell lymphoma causes|Causes]] ==
 
== [[Extranodal NK-T-cell lymphoma diagnosis|Differentiating Extranodal NK-T-cell lymphoma from other Diseases]] ==
 
== [[Extranodal NK-T-cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]==
 
== [[Extranodal NK-T-cell lymphoma risk factors|Risk Factors]] ==
 
== [[Extranodal NK-T-cell lymphoma, complications and prognosis|Natural History, Complications and Prognosis]] ==
 
== Diagnosis ==
[[Extranodal NK-T-cell lymphoma history and symptoms|History and Symptoms]] | [[Extranodal NK-T-cell lymphoma physical examination|Physical Examination]] | [[Extranodal NK-T-cell lymphoma laboratory findings|Laboratory Findings]] | [[Extranodal NK-T-cell lymphoma CT|CT]] | [[Extranodal NK-T-cell lymphoma other diagnostic studies|Other Diagnostic Studies]]
 
== Treatment ==
 
[[Extranodal NK-T-cell lymphoma medical therapy|Medical Therapy]] | [[Extranodal NK-T-cell lymphoma surgery|Surgery]] | [[Extranodal NK-T-cell lymphoma primary prevention|Primary Prevention]] | [[Extranodal NK-T-cell lymphoma secondary prevention|Secondary Prevention]] | [[Extranodal NK-T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]] | [[Extranodal NK-T-cell lymphoma cost-effectiveness of therapy | Cost Effectiveness of Therapy]]
 
==Case Studies==
:[[Extranodal NK-T-cell lymphoma case study one|Case #1]]


[[RNAi]] against [[EBNA1]] has been proposed as a possible treatment.<ref name="pmid18769118">{{cite journal |author=Ian MX, Lan SZ, Cheng ZF, Dan H, Qiong LH |title=Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells |journal=Cancer Biol. Ther. |volume=7 |issue=10 |pages=1602–6 |year=2008 |month=October |pmid=18769118 |doi= |url=http://www.landesbioscience.com/journals/cbt/abstract.php?id=6564}}</ref>


==References==
==References==

Revision as of 20:21, 12 February 2015

Extranodal NK-T-cell lymphoma
ICD-O: Template:ICDO
MeSH D054391

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords:

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extranodal NK-T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | CT | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Future or Investigational Therapies | Cost Effectiveness of Therapy

Case Studies

Case #1


References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Extranodal_NK-T-cell_lymphoma&oldid=1067387"